NEW YORK (GenomeWeb) – Molecular diagnostics firm OvaGene announced on Thursday an R&D collaboration with Hitachi Chemical Research Center to develop novel mRNA-based signatures for gynecological cancers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.